...
首页> 外文期刊>European review for medical and pharmacological sciences. >The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke
【24h】

The expression research of miR-210 in the elderly patients with COPD combined with ischemic stroke

机译:miR-210在老年COPD合并缺血性卒中患者中的表达研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: We conduct this study to investigate the expression level of miR-210 in elderly patients with COPD combined with ischemic stroke and analyzed its application value as a sensitive diagnostic indicator. PATIENTS AND METHODS: 50 cases of elderly patients with COPD combined with ischemic stroke were selected as group A, 50 cases of elderly patients with COPD were selected as group B, 50 cases of elderly patients with ischemic stroke were selected as group C, and 50 cases of healthy volunteers as group D. Real-time PCR assay for quantification was used to detect the expression level of miR-210 in peripheral blood and receiver operating curve (ROC) was used to analyze the diagnostic sensitivity and accuracy. RESULTS: MiR-210 level of group A was the lowest, followed by group B and group C; group D had the highest levels. The difference was statistically significant ( p <0.05). MiR-210 levels decreased with an increasing decline degree of lung function and the difference was statistically significant ( p <0.05). After miR-210 diagnosis, COPD sensitivity was 85.6%, the specificity was 72.6%, accuracy (AUC) was 0.821, and 95% CI 0.632-0.924. CONCLUSIONS: The down-regulation of MiR-210 expression in the COPD combined with ischemic stroke can be regarded as a sensitive index in diagnosis of COPD and ischemic stroke.
机译:目的:本研究旨在探讨miR-210在老年COPD合并缺血性卒中患者中的表达水平,并分析其作为敏感诊断指标的应用价值。病人和方法:将50例老年COPD合并缺血性脑卒中患者作为A组,将50例COPD老年患者作为B组,将50例缺血性脑卒中的老年患者作为C组,将50例老年人作为缺血性脑卒中。 D组为健康志愿者。采用实时荧光定量PCR检测外周血中miR-210的表达水平,并采用受试者工作曲线(ROC)分析诊断的敏感性和准确性。结果:MiR-210水平最低的是A组,其次是B组和C组。 D组的水平最高。差异具有统计学意义(p <0.05)。随着肺功能下降程度的增加,MiR-210水平降低,差异具有统计学意义(p <0.05)。经miR-210诊断后,COPD敏感性为85.6%,特异性为72.6%,准确度(AUC)为0.821,95%CI为0.632-0.924。结论:COPD和缺血性卒中合并MiR-210表达下调可作为诊断COPD和缺血性卒中的敏感指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号